COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,281 Articles (22,759 medRxiv, 8,522 bioRxiv)

Most recent first Previous |  Page 506: Articles 5051-5060  | Next

The effects of physiotherapy programs in COVID-19 patients during admission in the hospital
Jianramas, N., Nissapatorn, V., Sivakorn, C., Pereira, M. d. L., Ratnarathon, A. C., Salesingh, C., Jaiyen, E., Chaiyakul, S., Piya-amornphan, N., Semphuet, T., Thiangtham, T., Boontam, K., Longlalerng, K.
10.1101/2023.01.27.23285094 — Posted: 2023-01-28
COVID-19-related burnout reduces COVID-19 vaccination intention in cardiac patients: a cross-sectional study in Greece
Galanis, P. A., Katsiroumpa, A., Vraka, I., Siskou, O., Konstantakopoulou, O., Kaitelidou, D.
10.1101/2023.01.27.23285082 — Posted: 2023-01-28
Exploring the Transmission Dynamics of the COVID-19 Outbreaks after Dec. 2022 in Shaanxi Province, China: Analysis of Baseline Data from A Large Scale Cohort
Zhang, T., Mi, B., Shen, M., Nian, Y., Cao, S., Liu, J., Huang, H., Wei, Z., Liu, L., Wu, Q., Zhang, Y., Zhang, S.
10.1101/2023.01.24.23284952 — Posted: 2023-01-28
Longitudinal home self-collection of capillary blood using homeRNA correlates interferon and innate viral defense pathways with SARS-CoV-2 viral clearance
Lim, F. Y., Kim, S.-Y., Kulkarni, K. N., Blazevic, R. L., Kimball, L. E., Lea, H. G., Haack, A. J., Gower, M. S., Stevens-Ayers, T., Starita, L. M., Boeckh, M., Schiffer, J. T., Hyrien, O., Theberge, A. B., Waghmare, A.
10.1101/2023.01.24.23284913 — Posted: 2023-01-28
Effectiveness of a chatbot in improving the mental wellbeing of health workers in Malawi during the COVID-19 pandemic: A randomized, controlled trial
Kleinau, E., Lamba, T., Jaskiewicz, W., Gorentz, K., Hungerbuehler, I., Rahimi, D., Kokota, D., Maliwichi, L., Jamu, E., Zumazuma, A., Negrao, M., Mota, R., Khouri, Y., Kapps, M.
10.1101/2023.01.24.23284959 — Posted: 2023-01-28
What interventions or best practice are there to support people with Long COVID, or similar post-viral conditions or conditions characterised by fatigue, to return to normal activities: a rapid review
Spencer, L. H., Hendry, A., Makanjuola, A., Anthony, B. F., Davies, J., Pisavadia, K., Hughes, D., Fitzsimmons, D., Wilkinson, C., Edwards, R. T., Lewis, R., Cooper, A., Edwards, A. G.
10.1101/2023.01.24.23284947 — Posted: 2023-01-28
Infection of equine bronchial epithelial cells with a SARS-CoV-2 pseudovirus
Legere, R. M., Allegro, A. R., Affram, Y., Petri da Silveira, B., Fridley, J. L., Wells, K. M., Oezguen, N., Burghardt, R. C., Wright, G. A., Pollet, J., Bordin, A. I., de Figueiredo, P., Leibowitz, J. L., Cohen, N. D.
10.1101/2023.01.26.525770 — Posted: 2023-01-27
The lung employs an intrinsic surfactant-mediated inflammatory response for viral defense
Leibel, S. L., McVicar, R. N., Murad, R., Kwong, E. M., Clark, A. E., Alvarado, A., Grimmig, B. A., Nuryyev, R., Young, R. E., Lee, J. C., Peng, W., Zhu, Y. P., Griffis, E., Nowell, C. J., James, B., Alarcon, S., Malhotra, A., Gearing, L. J., Hertzog, P. J., Galapate, C. M., Galenkamp, K. M. O., Commisso, C., Smith, D. M., Sun, X., Carlin, A. F., Croker, B. A., Snyder, E. Y.
10.1101/2023.01.26.525578 — Posted: 2023-01-27
The Omicron variant BQ.1* with mutations at positions 28,311 and 28,312 in the SARS-CoV-2 N gene have minimal impact on CDC N1 target detection
Ren, G., Langhorst, B. W., Patton, G. C.
10.1101/2023.01.26.525759 — Posted: 2023-01-27
Identification of a molnupiravir-associated mutational signature in SARS-CoV-2 sequencing databases
Sanderson, T., Hisner, R., Donovan-Banfield, I., Peacock, T., Ruis, C.
10.1101/2023.01.26.23284998 — Posted: 2023-01-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).